Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


J Am Soc Nephrol 18: 2189-2197, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2007010066

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Lind van Wijngaarden, R. A.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Lind van Wijngaarden, R. A.F.

CLINICAL RESEARCH

Chances of Renal Recovery for Dialysis-Dependent ANCA-Associated Glomerulonephritis

Robert A.F. de Lind van Wijngaarden*, Herbert A. Hauer{dagger}, Ron Wolterbeek{ddagger}, David R.W. Jayne§, Gill Gaskin||, Niels Rasmussen, Laure-Hélène Noël**, Franco Ferrario{dagger}{dagger}, Rüdiger Waldherr{ddagger}{ddagger}, Jan A. Bruijn*, Ingeborg M. Bajema*, E. Christiaan Hagen§§ for the European Vasculitis Study Group (EUVAS)

Departments of * Pathology; {ddagger} Medical Statistics, Leiden University Medical Center, Leiden; {dagger} Department of Cardiology, Vrije Universiteit Medical Center, Amsterdam; §§ Department of Internal Medicine, Meander Medical Center, Amersfoort, Netherlands; § Renal Unit, Addenbrooke's Hospital, Cambridge; || Renal Unit, Hammersmith Hospital, London, United Kingdom; Otolaryngology, Rigshospitalet, Copenhagen, Denmark; ** INSERM U507, Hôpital Necker, Paris, France; {dagger}{dagger} Renal Immunopathology Center, Ospedale San Carlo Borromeo, Milan, Italy; and {ddagger}{ddagger} Department of Pathology, University of Heidelberg, Heidelberg, Germany

Correspondence: Dr. Rob de Lind van Wijngaarden, Department of Pathology, Leiden University Medical Center, Albinusdreef 2, PO Box 9600, 2300 RC Leiden, Netherlands. Phone: +31-71-526-6574; Fax: +31-71-524-8158; E-mail: r.a.f.de_lind_van_wijngaarden{at}lumc.nl

Received for publication January 18, 2007. Accepted for publication March 30, 2007.

In patients who have anti-neutrophil cytoplasm autoantibody (ANCA)-associated glomerulonephritis and are on dialysis at time of diagnosis, renal function is sometimes insufficiently restored by immunosuppressive treatment, which often coincides with potentially lethal adverse effects. This study investigated the clinical and histologic variables that determine the chances of dialysis independence, dialysis dependence, or death after 12 mo in these patients. Sixty-nine patients who had ANCA-associated glomerulonephritis and were dialysis dependent at diagnosis received uniform, standard immunosuppressive therapy plus either intravenous methylprednisolone or plasma exchange. Eleven clinical and histologic variables were assessed. Univariate and binary logistic regression analyses were performed. Predictive parameters were entered into a two-step binary logistic regression analysis to differentiate among the outcomes of dialysis independence, dialysis dependence, or death. The point at which the chance of therapy-related death exceeded the chance of dialysis independence was determined. The chance of recovery exceeded the chance of dying in most cases. Intravenous methylprednisolone as adjunctive therapy plus <18% normal glomeruli and severe tubular atrophy increased the chance of therapy-related death over the chance of dialysis independence. Plasma exchange treatment plus severe tubular atrophy and <2% normal glomeruli increased the chance of therapy-related death over that of dialysis independence. Even with ominous histologic findings, the chance of renal recovery exceeds the chance of therapy-related death when these patients are treated with plasma exchange as adjunctive therapy.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
S. Lionaki and R. J. Falk
Removing Antibody and Preserving Glomeruli in ANCA Small-Vessel Vasculitis
J. Am. Soc. Nephrol., July 1, 2007; 18(7): 1987 - 1989.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP